650,000+ Research Compounds In Stock Order Online
Our clients include world's top universities and pharmaceutical
organizations
Late-breaking elafibranor primary sclerosing cholangitis (PSC) data demonstrates favorable safety profile and significant efficacy in second potential rare liver disease indication
Ipsen
Thursday, April 24, 2025
Innate Pharma announces €15m investment by Sanofi
Innate Pharma
Thursday, April 24, 2025
Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes
GlobeNewswire
Thursday, April 24, 2025
HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2025
HUTCHMED
Thursday, April 24, 2025
CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade
Nature
Tuesday, April 22, 2025
Cognitive behavioral therapy skills via a smartphone app for subthreshold depression among adults in the community: the RESiLIENT randomized controlled trial
Nature
Tuesday, April 22, 2025
Effects of glacial forcing on lithospheric motion and ridge spreading
Nature
Tuesday, April 22, 2025
Psychedelic control of neuroimmune interactions governing fear
Nature
Tuesday, April 22, 2025
0 views 0 comments
Discover the Groundbreaking Potential of CRISPR Libraries in Gene Editing!
0 views 0 comments
Lung Cancer/ Side effects/
12 views 0 comments
Dr. Triparna Sen on Why Small Cell Lung Cancer Needs More Attention
Press Release: Sanofi: strong Q1 performance and 2025 guidance confirmed
Sanofi
Thursday, April 24, 2025
Ono Pharma Announces an Oral Presentation on Phase 2 Data for Tirabrutinib and a Poster Session on ONO-4578 (EP4 Antagonist) at the American Society of Clinical Oncology (ASCO) Annual Meeting
ono-pharma.com
Thursday, April 24, 2025
Hikma reiterates full year guidance following good start to the year
Hikma Pharmaceuticals
Thursday, April 24, 2025
Pharming Group to report first quarter 2025 financial results on May 8
Pharming Group
Thursday, April 24, 2025
Deciphering disordered regions controlling mRNA decay in high-throughput
Nature
Tuesday, April 22, 2025
Modular chiral origami metamaterials
Nature
Tuesday, April 22, 2025
A distributed coding logic for thermosensation and inflammatory pain
Nature
Tuesday, April 22, 2025
Quantum twisting microscopy of phonons in twisted bilayer graphene
Nature
Tuesday, April 22, 2025
24 views 1 comments
Goodie Mob - Cell Therapy | Memphis Jookin | OG Jawz & Birdy
0 views 0 comments
What Are The Different Types Of Pet Therapy? - Oncology Support Network
0 views 0 comments
The Providers of Compass Oncology
PharmaMar´s lurbinectedin transformative data in combination with atezolizumab for small cell lung cancer will be shared as oral presentation at ASCO 2025
Pharma Mar
Thursday, April 24, 2025
Supernus Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 6, 2025
Supernus Pharmaceuticals
Wednesday, April 23, 2025
Aptose Announces Auditor Not Standing for Re-Appointment
Aptose Biosciences
Wednesday, April 23, 2025
Viking Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
Viking Therapeutics
Wednesday, April 23, 2025
Targeting PIKfyve-driven lipid metabolism in pancreatic cancer
Nature
Tuesday, April 22, 2025
Genomic and genetic insights into Mendel’s pea genes
Nature
Tuesday, April 22, 2025
Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer
Nature
Tuesday, April 22, 2025
Atomic lift-off of epitaxial membranes for cooling-free infrared detection
Nature
Tuesday, April 22, 2025
2 views 0 comments
Holt challenge 2025 Pfizer/Johnson & Johnson
400 views 18 comments
Mais pourquoi Sanofi vend son Doliprane ? #sanofi #pfizer
0 views 0 comments
Trump tariffs Pharma #shorts #switzerland #Novartis
Xilio Therapeutics to Present Updated Phase 2 Data for Vilastobart, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, in Combination with Atezolizumab in Patients with Microsatellite Stable Colorectal Cancer at the 2025 ASCO Annual Meeting
Xilio Therapeutics
Wednesday, April 23, 2025
Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025
CRISPR Therapeutics
Wednesday, April 23, 2025
Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event
CRISPR Therapeutics
Wednesday, April 23, 2025
Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 7, 2025
ACADIA Pharmaceuticals
Wednesday, April 23, 2025
Geographic and age variations in mutational processes in colorectal cancer
Nature
Tuesday, April 22, 2025
Long-distance coherent quantum communications in deployed telecom networks
Nature
Tuesday, April 22, 2025
BMAL1–HIF2A heterodimer modulates circadian variations of myocardial injury
Nature
Tuesday, April 22, 2025
Melt focusing along lithosphere–asthenosphere boundary below Axial volcano
Nature
Tuesday, April 22, 2025
0 views 0 comments
Why the U.S. Must Advance in Stem Cell Therapy
4 views 0 comments
Novo Nordisk | Investimento em Montes Claros (MG)
0 views 0 comments
What Are The Different Types Of Phytochemicals? - Oncology Support Network
Powered by Arctom Copyright © 2025 Arctom.
All rights reserved.